Table 1 Characteristics of the cALL survivor cohort
Full cohort | LD/No CRT | LD/CRT | HD/CRT | |
|---|---|---|---|---|
(n = 241) | (n = 99) | (n = 82) | (n = 60) | |
Obesity | 76 (31.5%) | 27 (27.3%) | 30 (36.6%) | 19 (31.7%) |
Insulin resistance | 41 (17.0%) | 13 (13.1%) | 15 (18.3%) | 13 (21.7%) |
(Pre-)hypertension | 29 (12.0%) | 8 (8.08%) | 12 (14.6%) | 9 (15.0%) |
Dyslipidemia | 97 (40.2%) | 30 (30.3%) | 37 (45.1%) | 30 (50.0%) |
Gender (male) | 118 (49.0%) | 41 (41.4%) | 45 (54.9%) | 32 (53.3%) |
Corticosteroid dose (mg/m2) | 11,192 (5169) | 7603 (1322) | 9747 (2480) | 19,087 (3071) |
Age at diagnosis (years) | 6.59 (4.59) | 5.30 (3.43) | 7.91 (5.18) | 6.91 (4.89) |
Time since diagnosis (years) | 15.4 (5.10) | 14.0 (4.74) | 14.4 (5.42) | 18.9 (3.33) |
WBC count at diagnosis (109/L) | 30.2 (53.4) | 8.28 (7.84) | 40.5 (58.8) | 52.2 (72.7) |